Back
Monopar Therapeutics Stock Price Chart
Meet the founder that's revolutionizing smartphones
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
17
MNPR
Monopar Therapeutics
Last Price:
$29.48
Seasonality Move:
-9.44%
7 Day Trial
ALL ACCESS PASS
$
7
Crowdfunding to IPO: Nasdaq's Next Breakout?
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MNPR is experiencing slight selling pressure.
Monopar Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 36.6 | Sell |
| 20-day SMA: | 35.41 | Sell |
| 50-day SMA: | 38.47 | Sell |
| 200-day SMA: | 17.81 | Buy |
| 8-day EMA: | 35.31 | Sell |
| 20-day EMA: | 36.03 | Sell |
| 50-day EMA: | 35.03 | Sell |
| 200-day EMA: | 22.36 | Buy |
Monopar Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.3 | Sell |
| Relative Strength Index (14 RSI): | 41.89 | Sell |
| Chaikin Money Flow: | -19867 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (30.35 - 39.15) | Sell |
| Bollinger Bands (100): | (21.11 - 40.13) | Sell |
Monopar Therapeutics Technical Analysis
| Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 28 | Mar 31 | Apr 1 | Apr 2 | Apr 3 | Apr 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 24 | 25 | 26 | 27 | 28 | 31 | 01 | 02 | 03 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Monopar Therapeutics Stock
Is Monopar Therapeutics Stock a Buy?
-
Monopar Therapeutics share price is 30.00 while MNPR 8-day simple moving average is 36.60, which is a Sell signal.
-
The stock price of MNPR is 30.00 while Monopar Therapeutics 20-day SMA is 35.41, which makes it a Sell.
-
Monopar Therapeutics 50-day simple moving average is 38.47 while MNPR share price is 30.00, making it a Sell technically.
-
MNPR stock price is 30.00 and Monopar Therapeutics 200-day simple moving average is 17.81, creating a Buy signal.
MNPR Technical Analysis vs Fundamental Analysis
Sell
17
Monopar Therapeutics (MNPR)
is a Sell
Is Monopar Therapeutics a Buy or a Sell?
-
Monopar Therapeutics stock is rated a SellThe current Monopar Therapeutics [MNPR] share price is $30.00. The Score for MNPR is 17, which is 66% below its historic median score of 50, and infers higher risk than normal.
Monopar Therapeutics Stock Info
Market Cap:
183.4M
Price in USD:
30.00
Share Volume:
42.4K
Monopar Therapeutics 52-Week Range
52-Week High:
54.30
52-Week Low:
1.72
Sell
17
Monopar Therapeutics (MNPR)
is a Sell
Monopar Therapeutics Share Price Forecast
-
What is the Monopar Therapeutics stock price today?The Monopar Therapeutics stock price is 30.00 USD today.
-
Will MNPR stock go up or go down?Monopar Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Monopar Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Monopar Therapeutics is overvalued.
Is Monopar Therapeutics Stock a Buy?
-
Monopar Therapeutics share price is 30.00 while MNPR 8-day exponential moving average is 35.31, which is a Sell signal.
-
The stock price of MNPR is 30.00 while Monopar Therapeutics 20-day EMA is 36.03, which makes it a Sell.
-
Monopar Therapeutics 50-day exponential moving average is 35.03 while MNPR share price is 30.00, making it a Sell technically.
-
MNPR stock price is 30.00 and Monopar Therapeutics 200-day simple moving average is 22.36, creating a Buy signal.
Fundamental Analysis of Monopar Therapeutics
Is Monopar Therapeutics a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.46 per share, an increase next quarter of $0.13 per share, a decrease this year of $0.86 per share, and an increase next year of $0.69 per share.
Technical Analysis of Monopar Therapeutics
Should I short Monopar Therapeutics stock?
-
MNPR Moving Average Covergence Divergence (MACD) indicator is -0.3, suggesting Monopar Therapeutics is a Sell
-
Monopar Therapeutics Relative Strength Index (RSI) is 41.89, which suggest Monopar Therapeutics is oversold
-
The Bollinger Bands (25) for Monopar Therapeutics is (30.35 - 39.15), which suggest Monopar Therapeutics is a Sell
-
The Bollinger Bands (100) for Monopar Therapeutics is (21.11 - 40.13), which suggest Monopar Therapeutics is a Sell
* Monopar Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.